Vertex Pharmaceuticals
VRTX • NASDAQ
Vertex Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Reshma Kewalramani, with a market cap of $113.64B.
Market Cap$113.64B
Employees5.4K
CEOReshma Kewalramani
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 4, 2026 · In 3 weeksQ1 2026
Financials
Vertex Pharmaceuticals FAQ
Common questions about Vertex Pharmaceuticals
Vertex Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 4, 2026. Analysts estimate revenue of $3.0B.
Vertex Pharmaceuticals has approximately 5,400 employees.